BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Jaguar Health readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Jaguar Health's drugs run\, from 
 ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06721871-1030@assetmemo.bio
DTSTAMP:20261121T005949Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Mytesi (Crofelemer): Phase 2/3 readout est. (NCT06721871)
DESCRIPTION:Mytesi (Crofelemer)\, phase 2/3.\nStudy: Ascending Doses of Cro
 felemer Powder for Oral Solution in Pediatric Microvillus Inclusion Diseas
 e (MVID)\nEstimated primary completion: December 2026. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/crofelemer#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT06721871
URL:https://assetmemo.bio/drug/crofelemer#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06904872-1030@assetmemo.bio
DTSTAMP:20261121T005949Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Mytesi (Crofelemer): Phase 2 readout est. (NCT06904872)
DESCRIPTION:Mytesi (Crofelemer)\, phase 2\, Short Bowel Syndrome.\nStudy: S
 afety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndro
 me and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)\nEsti
 mated primary completion: March 2027. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/crofelemer#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT06904872
URL:https://assetmemo.bio/drug/crofelemer#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
